{
  "ticker": "MX1",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02974312",
  "id": "02974312",
  "pages": 24,
  "price_sensitive": false,
  "date": "20250730",
  "time": "0923",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250730/pdf/06m9dcsnw22kby.pdf",
  "summary": "**Summary of Micro-X Ltd Investor Presentation (30 July 2025):**  \n\n- **Key Contracts & Funding:**  \n  - **$29m** total funding from US DHS for airport security checkpoint & baggage scanner prototypes (under testing).  \n  - **$25m** ARPA-H contract for portable full-body CT development ($12.5m initial phase).  \n  - **$8m** Australian Stroke Alliance contract for mobile head CT (trials starting 2H 2025).  \n  - **$5.6m** partnership with Billion Prima (SE Asia baggage scanner).  \n\n- **Commercial Highlights:**  \n  - Rover Plus sales: Supply contract signed with major US healthcare provider; **$4.0m** 1H FY25 revenue.  \n  - Head CT prototype produced world-first 3D images; human trials imminent.  \n  - Security division monetisation discussions ongoing (DHS/TSA tech).  \n\n- **Financials:**  \n  - Cash balance: **~$5.1m** (31 Mar 2025); **$5.0m** R&D rebate expected Dec-2025.  \n  - Market cap: **$44.0m** (share price: $0.065).  \n\n- **Upcoming Catalysts:**  \n  - Head CT ambulance trials (2025), regulatory submissions (2026).  \n  - TSA lab testing for security prototypes.  \n\n*Omitted: Governance/operational details, non-material partnerships, and forward-looking statements.*",
  "usage": {
    "prompt_tokens": 5145,
    "completion_tokens": 317,
    "total_tokens": 5462,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-29T23:42:50.751812"
}